comparemela.com

Latest Breaking News On - Postmenopause - Page 4 : comparemela.com

FDA OKs Elacestrant for ESR1+ Advanced, Metastatic Breast Cancer

The phase 3 data showed a 2-month progression-free survival benefit with elacestrant versus fulvestrant or an aromatase inhibitor.

Geneva
Genè
Switzerland
United-states
Vinay-prasad
Geneva-university-hospital
Drug-administration
Stemline-therapeutics-inc
University-of-california-san-francisco
Stemline-therapeutics
Medscape-medical-news
California-san-francisco

Global Women Health and Beauty Supplements Market (2022 to

Dublin, Nov. 03, 2022 (GLOBE NEWSWIRE) The "Global Women Health and Beauty Supplements Market (2022-2027) by Product, Consumer Group, Sales Channel,.

Qatar
Australia
Taiwan
United-states
United-kingdom
Brazil
China
Austria
Dublin
Ireland
Russia
Taisho

Menopause an Independent Risk Factor for Schizophrenia Relapse?

Antipsychotics become less effective as estrogen levels drop, making women with schizophrenia more vulnerable to relapse as they age, new research shows.

Finland
Netherlands
Toronto
Ontario
Canada
Groningen
Niuvanniemi
Norra-savolax
Finnish
Dutch
Iris-sommer
Mary-seeman

Menopause Symptoms Negatively Affect Women's Work

Roughly 1 in 8 women said issues stemming from menopause caused them to miss days of work, quit, retire, or be laid off, researchers said.

Wisconsin
United-states
Netherlands
American
Ekta-kapoor
Laurie-jeffers
York-university-langone-health
American-menopause-society
Midlife-health
North-american-menopause
Mayo-clinic
New-york-university-langone-health

NAMS Affirms Value of Hormone Therapy for Menopausal Women

Recent research supports individualized care to maximize benefits and minimize risks.

United-states
American
Stephanies-faubion
Women-health-initiative
American-menopause-society
Women-health
Research-gaps
Journal-of-the-north-american-menopause-society
Mayo-clinic-center
Health-initiative
North-american-menopause

vimarsana © 2020. All Rights Reserved.